Compare Abeona Therapeutics Inc (ABEO) vs ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $23.08. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, ProShares UltraShort Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | KOLD | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $7.23 | $49.39 |
52-Week Low | $4.17 | $13.58 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
KOLD trades at $23.29, down 0.64% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The stock faces support at $23 and resistance at $24. Recent natural gas market volatility, driven by weather patterns and LNG demand fluctuations, creates trading opportunities for this bearish natural gas ETF.
As a tactical trading instrument, KOLD offers exposure to inverse natural gas price movements amid heightened energy market volatility. Key risks include weather-driven demand shifts and geopolitical factors affecting gas prices, while the bullish technical setup suggests potential near-term upside for this specialized energy sector play.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About ProShares UltraShort Bloomberg Natural Gas ETF
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →
